Pursuant to the instruction and charter for the Nomination Committee adopted at the Annual General Meeting held on
Based on the above, the Nomination Committee for the Annual
Pernille Singer , appointed byBioinvest ApS Jens Bager , appointed byGL Capital AB Steen Christensen , appointed byNext Stage Ventures ApS Torbjørn Bjerke , Chairman of the Board of Directors
The members have appointed
The Nomination Committee's tasks for the Annual General Meeting 2022 are to propose a Chairman for the Annual General Meeting, members of the Board of Directors and Chairman of the Board of Directors as well as auditor. The Nomination Committee will also propose remuneration to members of the Board of Directors and the auditor. Finally, the Nomination Committee will propose principles for appointing the Nomination Committee (if the Nomination Committee considers that the current principles and instructions should be updated).
Shareholders are welcome to submit their proposals and views to the Nomination
The Nomination Committee's proposals will be announced in the notice for the Annual General Meeting 2022 and on SynAct's web site.
The information was submitted, through the agency of the contact person below, for publication on
For further information about SynAct
Jeppe Øvlesen
CEO,
Phone: +45 28 44 75 67
Mail: joo@synactpharma.com
CSO,
Phone: +45 40 15 66 69
Mail: tj@synactpharma.com
About SynAct Pharma AB
https://news.cision.com/synact/r/synact-pharma-announces-nomination-committee-in-respect-of-agm-2022,c3456378
https://mb.cision.com/Main/14427/3456378/1498313.pdf
(c) 2021 Cision. All rights reserved., source